Clinical Trials Browser

Phase 1 × perflutren × 90 days × Clear all

NCT07501650 2026-03-30

Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer

Phase 1 Recruiting

Head and Neck Neoplasms, Recurrence

NCT06171607 2026-02-02

Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses

Phase 1 Recruiting

Breast Neoplasms